Clinical Trials Directory

Trials / Completed

CompletedNCT05266638

Assessing Risk Factors for Radiological Complications After Transforaminal Lumbar Interbody Fusion

AgeTLIF - Assessing Risk Factors for Radiological Complications After Transforaminal Lumbar Interbody Fusion

Status
Completed
Phase
Study type
Observational
Enrollment
170 (actual)
Sponsor
University Hospital, Basel, Switzerland · Academic / Other
Sex
All
Age
55 Years
Healthy volunteers
Not accepted

Summary

This retrospective study is to determine whether age is a risk factor for postoperative complications in patients undergoing transforaminal lumbar interbody fusion; specifically whether the risk (odds) of implant failure and the need for revision surgery increases with age.

Detailed description

Spinal fusion is one of the most commonly performed surgical procedures for the treatment of degenerative spinal disease. Interbody fusion with cages reconstructs the anterior column through disc removal, allowing to maintain proper disc height despite weight bearing, while providing firm fixation of the spinal segments. Transforaminal lumbar interbody fusion (TLIF) has fewer complications and less intraoperative bleeding than posterior lumbar interbody fusion (PLIF). Elderly patients are at high risk for perioperative and postoperative complications after lumbar fusion. This retrospective study is to determine whether age is a risk factor for postoperative complications in patients undergoing transforaminal lumbar interbody fusion; specifically whether the risk (odds) of implant failure and the need for revision surgery increases with age.

Conditions

Interventions

TypeNameDescription
OTHERData collection (radiological parameters, outcome information) from electronic patient files in hospital data systemCollection of medical data and medical images (MRI, radiographs) of the lumbar spine and pelvis of patients having received TLIF with degenerative spinal diseases from the years 2015-2020 and statistical analysis of the coded data.

Timeline

Start date
2022-01-19
Primary completion
2022-05-05
Completion
2023-02-15
First posted
2022-03-04
Last updated
2024-02-20

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05266638. Inclusion in this directory is not an endorsement.